• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基础免疫学概述及其临床应用。

Overview of Basic Immunology and Clinical Application.

机构信息

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.

出版信息

Adv Exp Med Biol. 2020;1244:1-36. doi: 10.1007/978-3-030-41008-7_1.

DOI:10.1007/978-3-030-41008-7_1
PMID:32301008
Abstract

Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which includes macrophages, dendritic cells, natural killer cells, neutrophils, mast cells, B cells, and T cells are found in the core, the invasive margin, or the adjacent stromal or lymphoid component of the tumor. The immune infiltrate is heterogeneous and varies within a patient and between patients of the same tumor histology. The location, density, functionality, and cross-talk between the immune cells in the tumor microenvironment influence the nature of immune response, prognosis, and treatment outcomes in cancer patients. Therefore, an understanding of the characteristics of the immune cells and their role in tumor immune surveillance is of paramount importance to identify immune targets and to develop novel immune therapeutics in the war against cancer. In this chapter, we provide an overview of the individual components of the human immune system and the translational relevance of predictive biomarkers.

摘要

肿瘤作为一个复杂的结构网络存在,具有进化和逃避宿主免疫监视机制的能力。免疫微环境包括巨噬细胞、树突状细胞、自然杀伤细胞、中性粒细胞、肥大细胞、B 细胞和 T 细胞,存在于肿瘤的核心、浸润边缘或相邻的基质或淋巴成分中。免疫浸润是异质的,在患者内部和同一肿瘤组织学的患者之间存在差异。肿瘤微环境中免疫细胞的位置、密度、功能和相互作用影响癌症患者的免疫反应性质、预后和治疗结果。因此,了解免疫细胞的特征及其在肿瘤免疫监视中的作用对于确定免疫靶点和开发新型免疫治疗方法以对抗癌症至关重要。在本章中,我们概述了人类免疫系统的各个组成部分以及预测性生物标志物的转化相关性。

相似文献

1
Overview of Basic Immunology and Clinical Application.基础免疫学概述及其临床应用。
Adv Exp Med Biol. 2020;1244:1-36. doi: 10.1007/978-3-030-41008-7_1.
2
Overview of Basic Immunology and Translational Relevance for Clinical Investigators.基础免疫学概述及其对临床研究人员的转化相关性。
Adv Exp Med Biol. 2018;995:1-41. doi: 10.1007/978-3-030-02505-2_1.
3
Immune System in Action.免疫系统在行动。
Adv Exp Med Biol. 2021;1342:1-43. doi: 10.1007/978-3-030-79308-1_1.
4
Overview of Basic Immunology for Clinical Investigators.临床研究人员基础免疫学概述
Adv Exp Med Biol. 2017;995:1-31. doi: 10.1007/978-3-319-53156-4_1.
5
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.肿瘤基质重构与新型免疫疗法:基质衍生免疫生物标志物的前景。
J Immunother Cancer. 2018 Jul 3;6(1):65. doi: 10.1186/s40425-018-0376-0.
6
[Immune system and tumors].[免疫系统与肿瘤]
Ann Pathol. 2017 Feb;37(1):11-17. doi: 10.1016/j.annpat.2016.12.004. Epub 2017 Jan 31.
7
Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.肿瘤诱导的 T 细胞免疫抑制的机制及对抗这些效应的治疗方法。
Arch Pharm Res. 2015 Aug;38(8):1415-33. doi: 10.1007/s12272-015-0566-y. Epub 2015 Jan 30.
8
Translation of cancer immunotherapy from the bench to the bedside.癌症免疫疗法的从基础研究到临床应用的转化。
Adv Cancer Res. 2019;143:1-62. doi: 10.1016/bs.acr.2019.03.001. Epub 2019 May 2.
9
Targeting immune cells for cancer therapy.针对免疫细胞的癌症疗法。
Redox Biol. 2019 Jul;25:101174. doi: 10.1016/j.redox.2019.101174. Epub 2019 Mar 20.
10
Biomarkers for Checkpoint Inhibition.检查点抑制的生物标志物。
Am Soc Clin Oncol Educ Book. 2017;37:205-209. doi: 10.1200/EDBK_175463.

引用本文的文献

1
Identification of immune-related biomarkers for glaucoma using gene expression profiling.利用基因表达谱鉴定青光眼的免疫相关生物标志物。
Front Genet. 2024 Apr 17;15:1366453. doi: 10.3389/fgene.2024.1366453. eCollection 2024.
2
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer.使用 Toll 样受体激动剂降低癌症负担的应用及临床试验概况
NPJ Precis Oncol. 2023 Mar 8;7(1):26. doi: 10.1038/s41698-023-00364-1.
3
The immune system, cancer, and pathogens: It takes three to tango!免疫系统、癌症与病原体:三者共舞!
J Immunother Precis Oncol. 2021 May 14;4(2):33-34. doi: 10.36401/JIPO-21-X1. eCollection 2021 May.
4
The interaction of and DNA repair gene mutations and their impact on tumor mutation burden and immune response in human malignancies.[具体物质]与DNA修复基因突变的相互作用及其对人类恶性肿瘤中肿瘤突变负担和免疫反应的影响。 (注:原文中“of”后面缺少具体内容)
Am J Cancer Res. 2022 Apr 15;12(4):1866-1883. eCollection 2022.
5
High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.高迁移率族AT钩蛋白1作为肝细胞癌的预后生物标志物并与免疫浸润相关
Int J Gen Med. 2022 Jan 14;15:609-621. doi: 10.2147/IJGM.S344858. eCollection 2022.
6
Experimental study on preparation and anti-tumor efficiency of nanoparticles targeting M2 macrophages.靶向 M2 巨噬细胞的纳米粒的制备及抑瘤效率的实验研究。
Drug Deliv. 2021 Dec;28(1):943-956. doi: 10.1080/10717544.2021.1921076.